Stock Trends


Stock prices generally trend in one direction or the other. When there is more demand for shares than there is supply, the stock will trend higher. In a downtrend, supply outweighs demand, forcing the stock to trend lower. It is important to understand individual stock trends as well as the trend of the market in general. 

A stock can be in the midst of multiple, simultaneous trends. Sound confusing? It’s not. A stock may be in a long-term uptrend, an intermediate-term downtrend and a short-term uptrend. (FYI: We loosely define long-term as greater than one year, intermediate-term as more than two months but less than a year, and short-term as two months or less.)

For long-term investors, the long-term trend is most important. But when you’re ready to take action (buy or sell), the short- and intermediate-term trends can be extremely important. To assist you in identifying how a stock is trending you should use a trendline.

TrendlinesTrendlines help you determine the prevailing trend of a stock. If a stock is advancing, a trendline should be drawn as a straight line that connects at least three successively higher bottoms. When that line is broken, the uptrend has run its course and the stock will either move sideways or begin a downtrend of unknown duration and severity. (See figure 1.)

When dealing with a downtrend, the trendline should connect at least three successively lower tops. As long as the stock’s price remains below the trendline, the downtrend remains in effect. (See figure 2.)

If a stock decisively breaks through a trendline, the odds favor a reversal in trend. And as we discussed above, depending upon which trend you’re analyzing (long-, intermediate- or short-term), the ramifications of a trend break could be significant. If a long-term trend has been broken, it’s more significant than a short-term trend break.

More on Cabot Technical Analysis
Sign up for free Cabot Wealth Advisory e-newsletter

Headline News

Stock Picks

Loews Corp.

This undervalued stock has strong future earnings growth expectations.


Biogen is the market-share leader in treating multiple sclerosis.


One of Paul Godwin’s favorite stocks in his Cabot Emerging Markets Investor portfolio.

Cabot Wealth Advisory

Tesla Model 3 vs. Chevy Bolt: Which Affordable Electric Car Is Better?

By Timothy Lutts on September 26, 2016

The Tesla Model 3 and Chevy Bolt are the first two affordable electric cars with a driving range of more than 200 miles. Let’s see how they stack up - and what they could mean to Tesla Motors (TSLA) and General Motors (GM) stock. Read More >

Does Alibaba (BABA) Stock Measure Up to Amazon (AMZN)?

By Paul Goodwin on September 23, 2016

Alibaba (BABA) is the Amazon (AMZN) of China. But does BABA stock measure up to AMZN stock? Let’s break it down!Read More >

As Stock Market Trends Change, Invest in these New Leaders

By Michael Cintolo on September 22, 2016

History tells us that all stock market trends change, and if you don’t recognize the leaders of that change early, you risk missing out on the next big winners.Read More >